Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Novel heterostructured Ge nanowires based on polytype transformation.

Vincent L, Patriarche G, Hallais G, Renard C, Gardès C, Troadec D, Bouchier D.

Nano Lett. 2014 Aug 13;14(8):4828-36. doi: 10.1021/nl502049a. Epub 2014 Jul 8.

PMID:
24988041
2.

100 nm AlSb/InAs HEMT for ultra-low-power consumption, low-noise applications.

Gardès C, Bagumako S, Desplanque L, Wichmann N, Bollaert S, Danneville F, Wallart X, Roelens Y.

ScientificWorldJournal. 2014 Feb 23;2014:136340. doi: 10.1155/2014/136340. eCollection 2014.

3.

Differential regulation of bile acid and cholesterol metabolism by the farnesoid X receptor in Ldlr -/- mice versus hamsters.

Gardès C, Chaput E, Staempfli A, Blum D, Richter H, Benson GM.

J Lipid Res. 2013 May;54(5):1283-99. doi: 10.1194/jlr.M033423. Epub 2013 Feb 21.

4.

Evidence of surface charge effects in T-branch nanojunctions using microsecond-pulse testing.

Iñiguez-de-la-Torre I, Mateos J, Roelens Y, Gardès C, Bollaert S, González T.

Nanotechnology. 2011 Nov 4;22(44):445203. doi: 10.1088/0957-4484/22/44/445203. Epub 2011 Oct 11.

PMID:
21990212
5.

Studies in mice, hamsters, and rats demonstrate that repression of hepatic apoA-I expression by taurocholic acid in mice is not mediated by the farnesoid-X-receptor.

Gardès C, Blum D, Bleicher K, Chaput E, Ebeling M, Hartman P, Handschin C, Richter H, Benson GM.

J Lipid Res. 2011 Jun;52(6):1188-99. doi: 10.1194/jlr.M012542. Epub 2011 Apr 4.

6.

Optimization of a novel class of benzimidazole-based farnesoid X receptor (FXR) agonists to improve physicochemical and ADME properties.

Richter HG, Benson GM, Bleicher KH, Blum D, Chaput E, Clemann N, Feng S, Gardes C, Grether U, Hartman P, Kuhn B, Martin RE, Plancher JM, Rudolph MG, Schuler F, Taylor S.

Bioorg Med Chem Lett. 2011 Feb 15;21(4):1134-40. doi: 10.1016/j.bmcl.2010.12.123. Epub 2010 Dec 31.

PMID:
21269824
7.

Discovery of novel and orally active FXR agonists for the potential treatment of dyslipidemia & diabetes.

Richter HG, Benson GM, Blum D, Chaput E, Feng S, Gardes C, Grether U, Hartman P, Kuhn B, Martin RE, Plancher JM, Rudolph MG, Schuler F, Taylor S, Bleicher KH.

Bioorg Med Chem Lett. 2011 Jan 1;21(1):191-4. doi: 10.1016/j.bmcl.2010.11.039. Epub 2010 Nov 12.

PMID:
21134747
8.

Effect of apoA-I on cholesterol release and apoE secretion in human mature adipocytes.

Bencharif K, Hoareau L, Murumalla RK, Tarnus E, Tallet F, Clerc RG, Gardes C, Cesari M, Roche R.

Lipids Health Dis. 2010 Jul 20;9:75. doi: 10.1186/1476-511X-9-75.

9.

[Orthodontic approach to asymmetry].

Bardinet E, Baron P, Bazert C, Boileau MJ, Bougues R, de Brondeau F, Darqué F, Faure J, Gardes C, Garnier E, Milheau JF, Nakache C, Pujol A, Treil J.

Orthod Fr. 2002 Sep;73(3):243-315. Review. French.

PMID:
12064070
10.

Mosaic genes and mosaic chromosomes: intra- and interspecies genomic variation of Streptococcus pneumoniae.

Hakenbeck R, Balmelle N, Weber B, Gardès C, Keck W, de Saizieu A.

Infect Immun. 2001 Apr;69(4):2477-86.

11.

Microarray-based identification of a novel Streptococcus pneumoniae regulon controlled by an autoinduced peptide.

de Saizieu A, Gardès C, Flint N, Wagner C, Kamber M, Mitchell TJ, Keck W, Amrein KE, Lange R.

J Bacteriol. 2000 Sep;182(17):4696-703.

Supplemental Content

Loading ...
Support Center